| 2025-02-05 |
股东大会：
将于2025-02-26召开股东大会
会议内容 ▼▲
- 1.The Divestiture Proposal — to approve by ordinary resolution the transactions contemplated by the Equity Exchange Agreement, dated January 31, 2025, by and among the Company, its wholly-owned subsidiary, Renovation Investment (Hong Kong) Co., Ltd., a Hong Kong private company (“Renovation”), Lei Liu, Chief Executive Officer and Chairman of the Board of the Company and Li Qi, a director of the Company, and Oakview International Limited, a Hong Kong private company co-owned by Mr. Liu and Ms. Qi (“Oakview”, collectively with Mr. Liu and Ms. Qi, the “Liu and Qi Parties”), pursuant to which the Company and Renovation agreed to sell all the ownership interests in Zhejiang Jiu Xin Investment Management Co. Ltd., a Chinese limited liability company wholly owned by Renovation, to Oakview in exchange for all ordinary shares of the Company owned by the Liu and Qi Parties and their affiliates;
2.The Acquisition Proposal — to approve by ordinary resolution the transactions including the issuance of ordinary shares, contemplated by the Equity Exchange Agreement, dated January 31, 2025, by and among the Company, Lingtao Kong, and Ridgeline International Limited, a Hong Kong private company (“Ridgeline”) wholly owned by Mr. Kong, pursuant to which Mr. Kong will sell all the ownership interests in Ridgeline to the Company in exchange for the issuance of 2,225,000 ordinary shares to Mr. Kong or his designee;
3.The Name Change Proposal — to approve by special resolution a change of the Company’s name from “China Jo-Jo Drugstores, Inc.” to “Ridgetech, Inc.”, and an alteration to the Company’s Third Amended and Restated Memorandum of Association and Articles of Association to refer to the new corporate name of the Company (the “Company Name Change”);
4.The Director Election Proposal — to approve by ordinary resolution the election of four directors to serve until the next annual meeting or until their successors are duly elected and qualified;
5.The Independent Accountants Ratification Proposal — to ratify by ordinary resolution the appointment of YCM CPA, Inc. as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2025;
6.The Capital Reduction Proposal — to approve by special resolution the Capital Reduction (as defined below), subject to and conditional upon, (i) the Company’s Board of Directors’ (the “Board”) approval to implement the Capital Reduction at such date and time in its sole discretion, but no later than the next annual general meeting of the Company, (ii) an order being made by the Grand Court of the Cayman Islands (the “Grand Court”) confirming the Capital Reduction; (iii) compliance with any condition which the Grand Court may impose in relation to the Capital Reduction; and (v) registration by the Registrar of Companies of the Cayman Islands of a copy of the order of the Grand Court confirming the Capital Reduction and the minutes approved by the Grand Court containing the particulars required under the Companies Act (As Revised) of the Cayman Islands (the “Companies Act”) in respect of the Capital Reduction, with effect from the date on which these conditions are fulfilled, to effect the following changes to the Company’s share capital: (a)the par value of each issued, ordinary share of the Company be reduced from US$0.24 (or the then current par value of each ordinary share) each to US$0.001 each (the “New Par Value”) by cancelling the paid-up capital to the extent of the difference between US$0.24 (or the then current par value) and the New Par Value on each of the then issued ordinary shares of the Company (the “Capital Reduction”), (b)immediately following the Capital Reduction, each of the authorized but unissued ordinary shares of the Company of par value of US$0.24 (or the then current par value) each be sub-divided (the “Share Subdivision”) into, for example, in case the then-current par value of the ordinary shares prior to the Capital Reduction equals to US$0.24, 240 new ordinary shares of par value of US$0.001 each (the “New Ordinary Shares”); (c)following the Capital Reduction, the credit arising from the Capital Reduction be transferred to a distributable reserve account of the Company which may be utilized by the Company as the Board may deem fit and permitted under the Companies Act, the memorandum and articles of association of the Company and all relevant applicable laws, including, without limitation, eliminating or setting off any accumulated losses of the Company from time to time; (d)each of the New Ordinary Shares arising from the Capital Reduction and the Share Subdivision shall rank pari passu in all respects with each other and each shall have rights and privileges and be subject to the restrictions as contained in the memorandum and the articles of association of the Company; (e)immediately following the Capital Reduction and the Share Subdivision, the authorized share capital of the Company will be changed from US$36,010,000 divided into (i) 150,000,000 ordinary shares of a par value of US$0.24 each (or, if following the Consolidation of Ordinary Shares (defined below) at the Approved Consolidation Ratio (defined below) of one-for-five (1:5), 30,000,000 ordinary shares of a par value of $1.20 each) and (ii) 10,000,000 preferred shares of a par value of US$0.001 each, to US$36,010,000 divided into (i) 36,000,000,000 New Ordinary Shares of a par value of US$0.001 each and (ii) 10,000,000 preferred shares of a par value of US$0.001 each; (f)any director of the Board be and is hereby authorized to do all such acts and things and execute all such documents, which are ancillary to the Capital Reduction and the Share Subdivision, on behalf of the Company, as he or she may consider necessary or expedient to give effect to, implement and complete the Capital Reduction and the Share Subdivision;
7.The Ordinary Share Consolidation Proposal — to approve by ordinary resolution the Board to effect a consolidation (the “Consolidation of Ordinary Shares”) of the Company’s authorized and issued ordinary shares, at a ratio of up to one-for-five (1:5) (the “Approved Consolidation Ratio”), on a date to be determined by the Board but no later than the next annual general meeting of the shareholders of the Company, with the exact ratio to be set at a whole number within this range, as determined by the Board in its sole discretion, such that the number of then authorized and issued ordinary shares of the Company is decreased by the Approved Consolidation Ratio, with the par value per ordinary share increased by the Approved Consolidation Ratio, and that the authorized share capital of the Company shall, subject to the shareholders’ approval of the Capital Reduction Proposal, be altered from US$36,010,000 divided into (i) 150,000,000 ordinary shares of a par value of US$0.24 each (or, if following the Capital Reduction and the Share Subdivision, 36,000,000,000 New Ordinary Shares of a par value of $0.001 each), and (ii) 10,000,000 preferred shares of a par value of US$0.001 each, to US$36,010,000 divided into (i) as low as 30,000,000 ordinary shares of a par value of US$1.20 each (or, if following the Capital Reduction and the Share Subdivision, 7,200,000,000 New Ordinary Shares of a par value of $0.005 each), and (ii) 10,000,000 preferred shares of a par value of US$0.001 each, to be implemented only if deemed necessary by the Board in its sole discretion to comply with Nasdaq Listing Rules;
8.The Articles Restatement Proposal — to approve by special resolution, subject to the shareholder approval of the Capital Reduction Proposal and the Ordinary Share Consolidation Proposal (as applicable), and only if the Board has effected a Capital Reduction and a Share Subdivision as authorized by the Capital Reduction Proposal and/or a Share Consolidation as authorized by the Ordinary Share Consolidation Proposal, the adoption of one or more newly amended and restated memorandum and articles of association to reflect the Capital Reduction, the Share Subdivision, the Consolidation of Ordinary Shares and the Company Name Change, as applicable;
9.To transact such other business as may properly come before the Annual General Meeting or any adjournment or postponement thereof.
|
| 2025-01-15 |
详情>>
业绩披露：
2025年中报每股收益-0.42美元,归母净利润-227.71万美元,同比去年增长-146.37%
|
| 2024-11-14 |
详情>>
股本变动：
变动后总股本617.84万股
|
| 2024-07-30 |
详情>>
业绩披露：
2024年年报每股收益-2.93美元,归母净利润-423.42万美元,同比去年增长79.97%
|
| 2024-03-20 |
详情>>
业绩披露：
2024年中报每股收益-0.77美元,归母净利润-92.42万美元,同比去年增长-55.39%
|
| 2024-03-01 |
复牌提示：
2024-02-29 19:50:00 停牌，复牌日期 2024-03-01 09:00:00
|
| 2024-02-27 |
详情>>
拆分方案：
每20.0000合并分成1.0000股
|
| 2024-01-26 |
股东大会：
将于2024-02-22召开股东大会
会议内容 ▼▲
- 1.To ratify the prior election of Mr. Lei Liu, Ms. Li Qi, Ms. Caroline Wang, Mr. Jiangliang He, Ms. Pingfan Wu, and Dr. Genghua Gu as directors of the Company to serve until the next Annual Meeting or until their successors are duly elected and qualified (the “Director Election Proposal”), who were previously elected at the Company’s annual meeting of shareholders for the fiscal year ended March 31, 2023 (the “2023 Annual Meeting”);
2.To re-ratify the prior appointment of YCM CPA, Inc. as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2024 (the “Independent Accountants Ratification Proposal”), which was previously ratified at the 2023 Annual Meeting;
3.To ratify the prior approval by ordinary resolution of the proposed reverse stock split and consolidation of the Company’s issued and outstanding ordinary shares (the “Share Consolidation Proposal”), which was previously adopted at the 2023 Annual Meeting;
4.To ratify the prior approval by ordinary resolution of the increase of authorised share capital (the “Authorised Share Capital Increase Proposal”), which was previously adopted at the 2023 Annual Meeting;
5.To ratify the prior approval by special resolution of the Amendment of the Memorandum and Articles of Association of the Company to effect the reverse stock split and consolidation of the Company’s issued and outstanding ordinary shares, and the increase of authorised share capital (the “Charter Amendment Proposal”), which was previously adopted at the 2023 Annual Meeting;
6.To ratify the prior approval of the Third Amended and Restated 2010 Equity Incentive Plan (the “Equity Incentive Plan Proposal”), which was previously adopted at the 2023 Annual Meeting;
7.To transact such other business as may properly come before the Extraordinary General Meeting or any adjournment thereof.
|
| 2023-11-14 |
股东大会：
将于2023-11-16召开股东大会
会议内容 ▼▲
- 1.To elect six directors to serve until the next Annual Meeting or until their successors are duly elected and qualified;
2.To ratify the appointment of YCM CPA, Inc. as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2024;
3.To approve by ordinary resolution the proposed reverse stock split and consolidation of the Company’s issued and outstanding ordinary shares;
4.To approve by ordinary resolution the increase of authorised share capital;
5.To approve by special resolution the Amendment of the Memorandum and Articles of Association of the Company to effect the reverse stock split and consolidation of the Company’s issued and outstanding ordinary shares, and the increase of authorised share capital;
6.To approve the Third Amended and Restated 2010 Equity Incentive Plan;
7.To transact such other business as may properly come before the Annual Meeting or any adjournment thereof.
|
| 2023-06-15 |
详情>>
业绩披露：
2023年年报每股收益-2.07美元,归母净利润-2113.85万美元,同比去年增长-562.21%
|
| 2023-01-20 |
详情>>
业绩披露：
2023年中报每股收益-0.13美元,归母净利润-59.48万美元,同比去年增长-126.37%
|
| 2022-11-03 |
股东大会：
将于2022-12-02召开股东大会
会议内容 ▼▲
- 1.To elect six directors to serve until the next Annual Meeting or until their successors are duly elected and qualified.
2.To ratify the appointment of YCM CPA, Inc. as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2023.
3.To approve the Second Amended and Restated 2010 Equity Incentive Plan.
4.To transact such other business as may properly come before the Annual Meeting or any adjournment thereof.
|
| 2022-07-28 |
详情>>
业绩披露：
2022年年报每股收益-0.92美元,归母净利润-319.21万美元,同比去年增长60.69%
|
| 2022-04-06 |
详情>>
拆分方案：
每12.0000合并分成1.0000股
|
| 2022-01-21 |
详情>>
业绩披露：
2022年中报每股收益-0.01美元,归母净利润-26.27万美元,同比去年增长84.77%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-06-29 |
详情>>
业绩披露：
2021年年报每股收益-0.2美元,归母净利润-811.99万美元,同比去年增长-39.68%
|
| 2021-06-02 |
股东大会：
将于2021-07-20召开股东大会
会议内容 ▼▲
- 1.to approve and adopt the agreement and plan of merger (the “Merger Agreement”) by and between the Company and China Jo-Jo Drugstores Holdings, Inc., an exempted company incorporated under the laws of the Cayman Islands and a wholly owned subsidiary of the Company (“CJJD Cayman”), which included a plan of merger required to be filed with the Register of Companies of the Cayman Islands, substantially in the form as attached as Annex A to the Merger Agreement (the “Plan of Merger”), pursuant to which the Company will merge with and into CJJD Cayman, with CJJD Cayman as the surviving company upon the merger becoming effective, and whereby each issued and outstanding share of the common stock of the Company will be converted into the right to receive one ordinary share of CJJD Cayman (the “Redomicile Merger”);
2.to transact such other business as may properly come before the Special Meeting or any adjournment or postponement thereof.
|
| 2021-02-12 |
详情>>
业绩披露：
2021年三季报(累计)每股收益-0.2美元,归母净利润-798.15万美元,同比去年增长-182.22%
|
| 2020-11-13 |
详情>>
业绩披露：
2021年中报每股收益-0.05美元,归母净利润-172.52万美元,同比去年增长48.65%
|
| 2020-09-14 |
股东大会：
将于2020-10-28召开股东大会
会议内容 ▼▲
- 1.To elect six directors to serve until the next Annual Meeting or until their successors are duly elected and qualified;
2.To ratify the appointment of BDO CHINA SHU LUN PAN Certified Public Accountants LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2021;
3.To approve the Amendment No.1 to our Amended and Restated 2010 Equity Incentive Plan;
4.To transact such other business as may properly come before the Annual Meeting or any adjournment thereof.
|
| 2020-01-21 |
股东大会：
将于2020-03-06召开股东大会
会议内容 ▼▲
- 1.To elect six directors to serve until the next Annual Meeting or until their successors are duly elected and qualified;
2.To ratify the appointment of BDO CHINA SHU LUN PAN Certified Public Accountants LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2020;
3.To approve our Amended and Restated 2010 Equity Incentive Plan;
4.To transact such other business as may properly come before the Annual Meeting or any adjournment thereof.
|
| 2019-01-24 |
股东大会：
将于2019-03-12召开股东大会
会议内容 ▼▲
- 1.To elect six directors to serve until the next Annual Meeting or until their successors are duly elected and qualified;
2.To ratify the appointment of BDO CHINA SHU LUN PAN Certified Public Accountants LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2019;
3.To transact such other business as may properly come before the Annual Meeting or any adjournment thereof.
|
| 2018-06-28 |
详情>>
内部人交易：
Liu Lei股份减少225000.00股
|
| 2018-02-09 |
股东大会：
将于2018-03-27召开股东大会
会议内容 ▼▲
- 1. To elect five directors to serve until the next Annual Meeting or until their successors are duly elected and qualified;
2. To amend the Company’s 2010 Equity Incentive Plan to increase by 2,500,000 shares that are available for issuance thereunder;
3. To ratify the appointment of BDO CHINA SHU LUN PAN Certified Public Accountants LLP as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2018;
4. To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission;
5. To transact such other business as may properly come before the Annual Meeting or any adjournment thereof.
|
| 2017-02-17 |
股东大会：
将于2017-03-29召开股东大会
会议内容 ▼▲
- 1.To elect five directors to serve until the next Annual Meeting or until their successors are duly elected and qualified;
2.To amend the Company’s 2010 Equity Incentive Plan to increase by 2,521,468 shares that are available for issuance thereunder;
3.To ratify the appointment of BDO CHINA SHU LUN PAN Certified Public Accountants LLP as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2017;
4.To transact such other business as may properly come before the Annual Meeting or any adjournment thereof.
|
| 2016-02-10 |
股东大会：
将于2016-03-24召开股东大会
会议内容 ▼▲
- 1.To elect five directors to serve until the next Annual Meeting or until their successors are duly elected and qualified;
2.To amend the Company’s 2010 Equity Incentive Plan to increase by 2,850,000 shares that are available for issuance thereunder;
3.To ratify the appointment of BDO CHINA SHU LUN PAN Certified Public Accountants LLP as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2016;
4.To transact such other business as may properly come before the Annual Meeting or any adjournment thereof.
|
| 2015-02-27 |
股东大会：
将于2015-03-24召开股东大会
会议内容 ▼▲
- 1.To elect five directors to serve until the next Annual Meeting or until their successors are duly elected and qualified;
2.To amend the Company’s 2010 Equity Incentive Plan to increase 2,300,000 shares that are available for issuance thereunder;
3.To ratify the appointment of Friedman LLP as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2015;
4.To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission;
5.To hold a non-binding advisory vote on the frequency of the advisory vote on executive compensation;
6.To transact such other business as may properly come before the Annual Meeting or any adjournment thereof.
|
| 2013-11-14 |
财报披露：
美东时间 2013-11-14 盘后发布财报
|